# SORENTO (NCT05050942)

> A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05050942
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Camurus AB
- Conditions: Gastro-enteropancreatic Neuroendocrine Tumor
- Interventions: CAM2029; Octreotide LAR; Lanreotide ATG
- Enrollment: 332
- Primary outcome: Progression-free survival (PFS) as assessed by a Blinded Independent Review Committee (BIRC)

## Commentary we found

- YouTube: 8
- Podcasts: 4

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=sorento-nct05050942

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05050942", "email": "<work email>"}; the inbox owner confirms by the emailed link.